Rhythm Pharmaceuticals Receives $21,000,000 Series A Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bd5a15f2-0627-4ac8-9495-35d79b904497&Preview=1 -
Date
3/15/2010 -
Company Name
Rhythm Pharmaceuticals -
Mailing Address
Undisclosed Boston, MA 02101 -
Company Description
Rhythm is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. -
Website
http://www.rhythmtx.com -
Transaction Type
Venture Equity -
Transaction Amount
$21,000,000 -
Transaction Round
Series A -
Proceeds Purposes
The funds will be used to develop products licensed from Ipsen (Euronext: IPN). -
M&A Terms
-
Venture Investor
MPM Capital -
Venture Investor
New Enterprise Associates
